Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study

Bruno Falissard(Inserm), Laurent Eckert(Sanofi (France)), Emma Guttman‐Yassky(Icahn School of Medicine at Mount Sinai), Adeline Abbé(Sanofi (France)), Grèce Saba(Kantar Health (Brazil)), S. Barbarot(Hotel Dieu Hospital), Laurene Gautier(Kantar Health (Brazil)), Kim Papp(University of Toronto), Abhijit Gadkari(Regeneron (United States)), Eric L. Simpson(Oregon Health & Science University)
Dermatology and Therapy
January 31, 2020
10.1007/s13555-020-00356-0
Cited by 34

Related Papers

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial
|The Lancet|2011|674
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
|British Journal of Dermatology|2020|590